From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
There are many obstacles preventing patients from starting and staying on therapy. Manufacturers need data-driven insights to take action and improve patient access. IntegriChain Patient Solutions provide actionable insights to help save patient days of therapy. In the specialty pharmacy world where patients are fighting for access to high-cost, life-saving therapies, we surface nuanced insights into patient access so manufacturers can create an optimal patient experience.
IntegriChain examined the quality and granularity of status/sub-status data across 40 specialty pharmacies representing different classes of trade (regional independent, mid-sized payer, large PBM, etc.). The records we combed through included 15 specialty brands in five therapeutic areas: Immunology, Hematology, Virology, Oncology, and Pulmonary/Respiratory.
Read Blog
There are several ways specialty brands can improve patient initiation by implementing data-driven patient support strategies. Successful interventions to streamline patient initiation have the potential to speed Time to First Fill and increase overall Fill Rate for new patient referrals. Each key opportunity to improve patient initiation is related to a friction point in patient access. This post provides an overview of these key opportunities and the potential of analytics to unlock efficiencies for specialty brands.
Brands are experiencing specialty pharmacy data quality issues. IntegriChain Specialty Data Refinery enriches patient sub-status records with metadata. Dozens of sub-status codes entered by the specialty pharmacy are then intelligently apportioned into customizable accrual stages such as Benefits Verification, Financial Counseling, and Prior Authorization.
Specialty Data Refinery
Current specialty data solutions fall short in delivering actionable insights to specialty brands. Available reports show what happened but don’t dive deeper to explain the why underlying key metric performance trends. IntegriChain Specialty Pharmacy Analytics surfaces multiple layers of insight to show brands the root cause of network underperformance and the payers, providers, and specialty pharmacies falling behind the average network trend.
Specialty Pharmacy Analytics
Inconsistent and poor quality specialty patient data leads to a healthy amount of skepticism of any conclusions drawn from the data. IntegriChain Specialty Pharmacy Analytics interprets the quality of patient substatus data reported by specialty pharmacies and presents an assessment of data quality across the network. Decisions related to specialty brands are now made with a better understanding as to the level of trust the data inspires.
Are specialty pharmacy performance metrics brand specific or is performance similar across a therapeutic category? IntegriChain Specialty Pharmacy Analytics reveals market basket comparative metrics for broader context.
